MP Advisors/Mehta Partners: Indian BioPharma Landscape – 2018
It is our pleasure to share with you our recent update on India's BioPharmaceutical Landscape. We have developed this evolving framework that has helped us assess various pharma markets and companies regardless of geography—an integrated perspective to help identify value drivers and global growth opportunities. Indian companies have predominantly thrived on globalizing their generic formulations business with a primary focus on the US market. However, increasing pricing pressure as a result of consolidation among payer groups and PBMs (Pharma Benefit Managers), and intensifying…